
Regulatory Considerations for Multispecific Antibody-Based Products for BLA and Beyond
Speaker Presentation: CMC Strategy Forum North America 2026
Swisher Jennifer, CDER. FDA, 2026
Regulatory Considerations for Multispecific Antibody-Based Products for BLA and Beyond